Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner
Authors
Keywords
-
Journal
Nature Communications
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-12-04
DOI
10.1038/ncomms6637
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sabutoclax, a Mcl-1 Antagonist, Inhibits Tumorigenesis in Transgenic Mouse and Human Xenograft Models of Prostate Cancer
- (2015) Roger S. Jackson et al. NEOPLASIA
- Beclin1: A role in membrane dynamics and beyond
- (2012) Ellen Wirawan et al. Autophagy
- Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors
- (2012) G. J. Gores et al. GENES & DEVELOPMENT
- Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance
- (2012) E. Bolesta et al. MOLECULAR AND CELLULAR BIOLOGY
- Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
- (2012) Rhonda M. Perciavalle et al. NATURE CELL BIOLOGY
- Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
- (2011) Junli Liu et al. CELL
- Targeting Mcl-1 for the therapy of cancer
- (2011) Bridget A Quinn et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Oncogenic Ras-Induced Expression of Noxa and Beclin-1 Promotes Autophagic Cell Death and Limits Clonogenic Survival
- (2011) Mohamed Elgendy et al. MOLECULAR CELL
- SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
- (2011) Hiroyuki Inuzuka et al. NATURE
- Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity
- (2011) R. Dash et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance
- (2010) K. J. Campbell et al. BLOOD
- MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner
- (2010) Marc Germain et al. EMBO JOURNAL
- Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
- (2010) Laura Bonapace et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of autophagy in tumour development and cancer therapy
- (2009) Mathias T. Rosenfeldt et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions
- (2009) Clelia Miracco et al. HUMAN PATHOLOGY
- Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
- (2009) K. Boisvert-Adamo et al. MOLECULAR CANCER RESEARCH
- Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
- (2009) Martin Schwickart et al. NATURE
- RNA Silencing of Mcl-1 Enhances ABT-737-Mediated Apoptosis in Melanoma: Role for a Caspase-8-Dependent Pathway
- (2009) Angela M. Keuling et al. PLoS One
- Up-regulation of Mcl-1 Is Critical for Survival of Human Melanoma Cells upon Endoplasmic Reticulum Stress
- (2008) C. C. Jiang et al. CANCER RESEARCH
- Mcl-1 is a potential therapeutic target in multiple types of cancer
- (2008) C. Akgul CELLULAR AND MOLECULAR LIFE SCIENCES
- Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
- (2008) Gordon Shore et al. CURRENT MOLECULAR MEDICINE
- Down-Regulation of Mcl-1 by Small Interfering RNA Sensitizes Resistant Melanoma Cells to Fas-Mediated Apoptosis
- (2008) N. Chetoui et al. MOLECULAR CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started